Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

A Quality Improvement Collaborative to Improve the Discharge Process for Hospitalized Children.

Wu S, Tyler A, Logsdon T, Holmes NM, Balkian A, Brittan M, Hoover L, Martin S, Paradis M, Sparr-Perkins R, Stanley T, Weber R, Saysana M.

Pediatrics. 2016 Aug;138(2). pii: e20143604. doi: 10.1542/peds.2014-3604.

2.

Summary of STARNet: Seamless Transitions and (Re)admissions Network.

Auger KA, Simon TD, Cooperberg D, Gay J, Kuo DZ, Saysana M, Stille CJ, Fisher ES, Wallace S, Berry J, Coghlin D, Jhaveri V, Kairys S, Logsdon T, Shaikh U, Srivastava R, Starmer AJ, Wilkins V, Shen MW.

Pediatrics. 2015 Jan;135(1):164-75. doi: 10.1542/peds.2014-1887. Epub 2014 Dec 8.

3.

Decreasing handoff-related care failures in children's hospitals.

Bigham MT, Logsdon TR, Manicone PE, Landrigan CP, Hayes LW, Randall KH, Grover P, Collins SB, Ramirez DE, O'Guin CD, Williams CI, Warnick RJ, Sharek PJ.

Pediatrics. 2014 Aug;134(2):e572-9. doi: 10.1542/peds.2013-1844. Epub 2014 Jul 7.

PMID:
25002665
4.

A multicenter collaborative approach to reducing pediatric codes outside the ICU.

Hayes LW, Dobyns EL, DiGiovine B, Brown AM, Jacobson S, Randall KH, Wathen B, Richard H, Schwab C, Duncan KD, Thrasher J, Logsdon TR, Hall M, Markovitz B.

Pediatrics. 2012 Mar;129(3):e785-91. doi: 10.1542/peds.2011-0227. Epub 2012 Feb 20. Erratum in: Pediatrics. 2012 Jul;130(1):168-9. Richard, Heather [added].

PMID:
22351886
5.

Sustaining and spreading the reduction of adverse drug events in a multicenter collaborative.

Tham E, Calmes HM, Poppy A, Eliades AB, Schlafly SM, Namtu KC, Smith DM, Vitaska MC, McConnell C, Potts AL, Jastrzembski J, Logsdon TR, Hall M, Takata GS.

Pediatrics. 2011 Aug;128(2):e438-45. doi: 10.1542/peds.2010-3772. Epub 2011 Jul 4.

PMID:
21727100
6.

Prevention of central venous catheter-associated bloodstream infections in pediatric intensive care units: a performance improvement collaborative.

Jeffries HE, Mason W, Brewer M, Oakes KL, Muñoz EI, Gornick W, Flowers LD, Mullen JE, Gilliam CH, Fustar S, Thurm CW, Logsdon T, Jarvis WR.

Infect Control Hosp Epidemiol. 2009 Jul;30(7):645-51. doi: 10.1086/598341.

PMID:
19496731
7.

An intervention to decrease narcotic-related adverse drug events in children's hospitals.

Sharek PJ, McClead RE Jr, Taketomo C, Luria JW, Takata GS, Walti B, Tanski M, Nelson C, Logsdon TR, Thurm C, Federico F.

Pediatrics. 2008 Oct;122(4):e861-6. doi: 10.1542/peds.2008-1011.

PMID:
18829784
8.

Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.

Takata GS, Mason W, Taketomo C, Logsdon T, Sharek PJ.

Pediatrics. 2008 Apr;121(4):e927-35. doi: 10.1542/peds.2007-1779.

PMID:
18381521
9.

Assessing postoperative pain in neonates: a multicenter observational study.

Taylor BJ, Robbins JM, Gold JI, Logsdon TR, Bird TM, Anand KJ.

Pediatrics. 2006 Oct;118(4):e992-1000.

PMID:
17015519
10.
11.

Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: acquisition of experimental data.

Lau C, Mole ML, Copeland MF, Rogers JM, Kavlock RJ, Shuey DL, Cameron AM, Ellis DH, Logsdon TR, Merriman J, Setzer RW.

Toxicol Sci. 2001 Jan;59(1):37-48.

PMID:
11134542
12.

Pharmacokinetics of (R,S)-Albuterol after aerosol inhalation in healthy adult volunteers.

Anderson PJ, Zhou X, Breen P, Gann L, Logsdon TW, Compadre CM, Hiller FC.

J Pharm Sci. 1998 Jul;87(7):841-4.

PMID:
9649352
13.

Determination of albuterol in plasma after aerosol inhalation by gas chromatography-mass spectrometry with selected-ion monitoring.

Logsdon TW, Zhou X, Breen P, Anderson P, Gann L, Hiller C, Compadre CM.

J Chromatogr B Biomed Sci Appl. 1997 May 9;692(2):472-7.

PMID:
9188839
14.

Gamma-glutamyl transferase (GGT) activity and biochemical characterization of rat visceral yolk-sac during gestation with or without trypan blue exposure.

Andrews JE, Ebron-McCoy M, Logsdon TR, Richards J, Rogers JM.

Reprod Toxicol. 1994 Sep-Oct;8(5):405-10.

PMID:
7841659
15.

Biologically based dose-response modeling in developmental toxicology: biochemical and cellular sequelae of 5-fluorouracil exposure in the developing rat.

Shuey DL, Lau C, Logsdon TR, Zucker RM, Elstein KH, Narotsky MG, Setzer RW, Kavlock RJ, Rogers JM.

Toxicol Appl Pharmacol. 1994 May;126(1):129-44.

PMID:
8184423
16.

Effects of methanol on embryonic mouse palate in serum-free organ culture.

Abbott BD, Logsdon TR, Wilke TS.

Teratology. 1994 Feb;49(2):122-34.

PMID:
8016743
17.

Fetal development in the rat following disruption of maternal renal function during pregnancy.

Kavlock RJ, Logsdon T, Gray JA.

Teratology. 1993 Sep;48(3):247-58.

PMID:
8248862
18.

Developmental toxicity of methanol in whole embryo culture: a comparative study with mouse and rat embryos.

Andrews JE, Ebron-McCoy M, Logsdon TR, Mole LM, Kavlock RJ, Rogers JM.

Toxicology. 1993 Aug 27;81(3):205-15.

PMID:
8212026
19.

Effects of 5-fluorouracil on embryonic rat palate in vitro: fusion in the absence of proliferation.

Abbott BD, Lau C, Buckalew AR, Logsdon TR, Setzer W, Zucker RM, Elstein KH, Kavlock RJ.

Teratology. 1993 Jun;47(6):541-54.

PMID:
8367827
20.

Developmental toxicity of bromohydroquinone (BHQ) and BHQ-glutathione conjugates in vivo and in whole embryo culture.

Andrews JE, Rogers JM, Ebron-McCoy M, Logsdon TR, Monks TJ, Lau SS.

Toxicol Appl Pharmacol. 1993 May;120(1):1-7.

PMID:
8099763
21.

The developmental toxicity of inhaled methanol in the CD-1 mouse, with quantitative dose-response modeling for estimation of benchmark doses.

Rogers JM, Mole ML, Chernoff N, Barbee BD, Turner CI, Logsdon TR, Kavlock RJ.

Teratology. 1993 Mar;47(3):175-88.

PMID:
8475461
22.

In vitro embryotoxicity of a series of para-substituted phenols: structure, activity, and correlation with in vivo data.

Oglesby LA, Ebron-McCoy MT, Logsdon TR, Copeland F, Beyer PE, Kavlock RJ.

Teratology. 1992 Jan;45(1):11-33.

PMID:
1731394
23.

UTERINE EFFECTS, EPIGENETICS, AND POSTNATAL SKELETAL DEVELOPMENT IN THE MOUSE.

Atchley WR, Logsdon T, Cowley DE, Eisen EJ.

Evolution. 1991 Jun;45(4):891-909. doi: 10.1111/j.1558-5646.1991.tb04358.x.

PMID:
28564060
24.

In vivo and in vitro structure-dosimetry-activity relationships of substituted phenols in developmental toxicity assays.

Kavlock RJ, Oglesby LA, Hall LL, Fisher HL, Copeland F, Logsdon T, Ebron-McCoy M.

Fundam Appl Toxicol. 1991 Feb;16(2):225-9. Review. No abstract available.

PMID:
2055353
25.

In vivo and in vitro structure-dosimetry-activity relationships of substituted phenols in developmental toxicity assays.

Kavlock RJ, Oglesby LA, Hall LL, Fisher HL, Copeland F, Logsdon T, Ebron-McCoy M.

Reprod Toxicol. 1991;5(3):255-8.

PMID:
1807560

Supplemental Content

Loading ...
Support Center